---
authors:
- ReactomeTeam
description: 'The AP-2 (TFAP2) family of transcription factors includes five proteins
  in mammals: TFAP2A (AP-2 alpha), TFAP2B (AP-2 beta), TFAP2C (AP-2 gamma), TFAP2D
  (AP-2 delta) and TFAP2E (AP-2 epsilon). The AP-2 family transcription factors are
  evolutionarily conserved in metazoans and are characterized by a helix-span-helix
  motif at the C-terminus, a central basic region, and the transactivation domain
  at the N-terminus. The helix-span-helix motif and the basic region enable dimerization
  and DNA binding (Eckert et al. 2005).<p>AP-2 dimers bind palindromic GC-rich DNA
  response elements that match the consensus sequence 5''-GCCNNNGGC-3'' (Williams
  and Tjian 1991a, Williams and Tjian 1991b). Transcriptional co-factors from the
  CITED family interact with the helix-span-helix (HSH) domain of TFAP2 (AP-2) family
  of transcription factors and recruit transcription co-activators EP300 (p300) and
  CREBBP (CBP) to TFAP2-bound DNA elements. CITED2 shows the highest affinity for
  TFAP2 proteins, followed by CITED4, while CITED1 interacts with TFAP2s with a very
  low affinity. Mouse embryos defective for CITED2 exhibit neural crest defects, cardiac
  malformations and adrenal agenesis, which can at least in part be attributed to
  a defective Tfap2 transactivation (Bamforth et al. 2001, Braganca et al. 2002, Braganca
  et al. 2003). Transcriptional activity of AP-2 dimers in inhibited by binding of
  KCTD1 or KCTD15 to the AP-2 transactivation domain (Ding et al. 2009, Zarelli and
  Dawid 2013). Transcriptional activity of TFAP2A, TFAP2B and TFAP2C is negatively
  regulated by SUMOylation mediated by UBE2I (UBC9) (Eloranta and Hurst 2002, Berlato
  et al. 2011, Impens et al. 2014, Bogachek et al. 2014).<p>During embryonic development,
  AP-2 transcription factors stimulate proliferation and suppress terminal differentiation
  in a cell-type specific manner (Eckert et al. 2005).<p>TFAP2A and TFAP2C directly
  stimulate transcription of the estrogen receptor ESR1 gene (McPherson and Weigel
  1999). TFAP2A expression correlates with ESR1 expression in breast cancer, and TFAP2C
  is frequently overexpressed in estrogen-positive breast cancer and endometrial cancer
  (deConinck et al. 1995, Turner et al. 1998). TFAP2A, TFAP2C, as well as TFAP2B can
  directly stimulate the expression of ERBB2, another important breast cancer gene
  (Bosher et al. 1996). Association of TFAP2A with the YY1 transcription factor significantly
  increases the ERBB2 transcription rate (Begon et al. 2005). In addition to ERBB2,
  the expression of another receptor tyrosine kinase, KIT, is also stimulated by TFAP2A
  and TFAP2B (Huang et al. 1998), while the expression of the VEGF receptor tyrosine
  kinase ligand VEGFA is repressed by TFAP2A (Ruiz et al. 2004, Li et al. 2012). TFAP2A
  stimulates transcription of the transforming growth factor alpha (TGFA) gene (Wang
  et al. 1997). TFAP2C regulates EGFR in luminal breast cancer (De Andrade et al.
  2016).<p>TFAP2C plays a critical role in maintaining the luminal phenotype in human
  breast cancer and in influencing the luminal cell phenotype during normal mammary
  development (Cyr et al. 2015).<p>In placenta, TFAP2A and TFAP2C directly stimulate
  transcription of both subunits of the human chorionic gonadotropin, CGA and CGB
  (Johnson et al. 1997, LiCalsi et al. 2000).<p>TFAP2A and/or TFAP2C, in complex with
  CITED2, stimulate transcription of the PITX2 gene, involved in left-right patterning
  and heart development (Bamforth et al. 2004, Li et al. 2012).<p>TFAP2A and TFAP2C
  play opposing roles in transcriptional regulation of the CDKN1A (p21) gene locus.
  While TFAP2A stimulates transcription of the CDKN1A cyclin-dependent kinase inhibitor
  (Zeng et al. 1997, Williams et al. 2009, Scibetta et al. 2010), TFAP2C represses
  CDKN1A transcription (Williams et al. 2009, Scibetta et al. 2010, Wong et al. 2012).
  Transcription of the TFAP2A gene may be inhibited by CREB and E2F1 (Melnikova et
  al. 2010).<p>For review of the AP-2 family of transcription factors, please refer
  to Eckert et al. 2005.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=8864260
  Reactome].'
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4086
- /instance/WP4086
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4086.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: 'The AP-2 (TFAP2) family of transcription factors includes five proteins
    in mammals: TFAP2A (AP-2 alpha), TFAP2B (AP-2 beta), TFAP2C (AP-2 gamma), TFAP2D
    (AP-2 delta) and TFAP2E (AP-2 epsilon). The AP-2 family transcription factors
    are evolutionarily conserved in metazoans and are characterized by a helix-span-helix
    motif at the C-terminus, a central basic region, and the transactivation domain
    at the N-terminus. The helix-span-helix motif and the basic region enable dimerization
    and DNA binding (Eckert et al. 2005).<p>AP-2 dimers bind palindromic GC-rich DNA
    response elements that match the consensus sequence 5''-GCCNNNGGC-3'' (Williams
    and Tjian 1991a, Williams and Tjian 1991b). Transcriptional co-factors from the
    CITED family interact with the helix-span-helix (HSH) domain of TFAP2 (AP-2) family
    of transcription factors and recruit transcription co-activators EP300 (p300)
    and CREBBP (CBP) to TFAP2-bound DNA elements. CITED2 shows the highest affinity
    for TFAP2 proteins, followed by CITED4, while CITED1 interacts with TFAP2s with
    a very low affinity. Mouse embryos defective for CITED2 exhibit neural crest defects,
    cardiac malformations and adrenal agenesis, which can at least in part be attributed
    to a defective Tfap2 transactivation (Bamforth et al. 2001, Braganca et al. 2002,
    Braganca et al. 2003). Transcriptional activity of AP-2 dimers in inhibited by
    binding of KCTD1 or KCTD15 to the AP-2 transactivation domain (Ding et al. 2009,
    Zarelli and Dawid 2013). Transcriptional activity of TFAP2A, TFAP2B and TFAP2C
    is negatively regulated by SUMOylation mediated by UBE2I (UBC9) (Eloranta and
    Hurst 2002, Berlato et al. 2011, Impens et al. 2014, Bogachek et al. 2014).<p>During
    embryonic development, AP-2 transcription factors stimulate proliferation and
    suppress terminal differentiation in a cell-type specific manner (Eckert et al.
    2005).<p>TFAP2A and TFAP2C directly stimulate transcription of the estrogen receptor
    ESR1 gene (McPherson and Weigel 1999). TFAP2A expression correlates with ESR1
    expression in breast cancer, and TFAP2C is frequently overexpressed in estrogen-positive
    breast cancer and endometrial cancer (deConinck et al. 1995, Turner et al. 1998).
    TFAP2A, TFAP2C, as well as TFAP2B can directly stimulate the expression of ERBB2,
    another important breast cancer gene (Bosher et al. 1996). Association of TFAP2A
    with the YY1 transcription factor significantly increases the ERBB2 transcription
    rate (Begon et al. 2005). In addition to ERBB2, the expression of another receptor
    tyrosine kinase, KIT, is also stimulated by TFAP2A and TFAP2B (Huang et al. 1998),
    while the expression of the VEGF receptor tyrosine kinase ligand VEGFA is repressed
    by TFAP2A (Ruiz et al. 2004, Li et al. 2012). TFAP2A stimulates transcription
    of the transforming growth factor alpha (TGFA) gene (Wang et al. 1997). TFAP2C
    regulates EGFR in luminal breast cancer (De Andrade et al. 2016).<p>TFAP2C plays
    a critical role in maintaining the luminal phenotype in human breast cancer and
    in influencing the luminal cell phenotype during normal mammary development (Cyr
    et al. 2015).<p>In placenta, TFAP2A and TFAP2C directly stimulate transcription
    of both subunits of the human chorionic gonadotropin, CGA and CGB (Johnson et
    al. 1997, LiCalsi et al. 2000).<p>TFAP2A and/or TFAP2C, in complex with CITED2,
    stimulate transcription of the PITX2 gene, involved in left-right patterning and
    heart development (Bamforth et al. 2004, Li et al. 2012).<p>TFAP2A and TFAP2C
    play opposing roles in transcriptional regulation of the CDKN1A (p21) gene locus.
    While TFAP2A stimulates transcription of the CDKN1A cyclin-dependent kinase inhibitor
    (Zeng et al. 1997, Williams et al. 2009, Scibetta et al. 2010), TFAP2C represses
    CDKN1A transcription (Williams et al. 2009, Scibetta et al. 2010, Wong et al.
    2012). Transcription of the TFAP2A gene may be inhibited by CREB and E2F1 (Melnikova
    et al. 2010).<p>For review of the AP-2 family of transcription factors, please
    refer to Eckert et al. 2005.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=8864260
    Reactome].'
  keywords:
  - TFAP2A,TFAP2C
  - TGFA Gene
  - homodimer:APOE gene
  - 'CGA Gene '
  - 'TFAP2A-1-G97-SUMO1 '
  - ATAD2
  - 'EGFR gene '
  - 'SUMO1-K10-TFAP2C '
  - homodimer:MYBL2
  - DEK:TFAP2A
  - VEGFA gene
  - 'CITED2 '
  - ATAD2:ESR1
  - TFAP2B
  - PITX2
  - 'KDM5B '
  - 'SUMO1-K10-TFAP2A-1 '
  - homodimer:TGFA gene
  - VEGFA
  - NPM1
  - ESR1
  - 'KCTD15 '
  - HSPD1
  - 'ERBB2 Gene '
  - homodimers
  - ERBB2
  - MYC
  - ESR1 Gene
  - homodimers:CGA Gene
  - 'MYBL2 gene '
  - 'ESR1 '
  - 'TFAP2C '
  - MYBL2
  - 'CITED4 '
  - homodimer:HSPD1
  - 'DEK '
  - 'MYC '
  - 'KIT Gene '
  - DEK:TFAP2A homodimer
  - NPM1:TFAP2A
  - 'PITX2 Gene '
  - homodimer:EGFR gene
  - homodimers:KIT gene
  - 'NOP2 gene '
  - TGFA precursor
  - Gonadotropin
  - NOP2
  - EGFR
  - WWOX
  - CGA
  - CREBBP
  - homo-
  - homodimer:MYC:KDM5B
  - heterodimers:KCTD1
  - TFAP2C:WWOX
  - 'CGB3 '
  - Gene
  - KIT
  - heterodimers:KCTD15
  - TFAP2C homodimer
  - 'TFAP2B-G97-SUMO1 '
  - 'TFAP2E '
  - homodimer:NOP2 gene
  - homodimer:CDKN1A
  - TFAP2A homodimer
  - TFAP2
  - YY1
  - ERBB2 Gene
  - TFAP2 homo- and
  - atRA
  - SUMO1:TFAP2A-1
  - APOE gene
  - 'SUMO1-C93-UBE2I '
  - 'TGFA Gene '
  - CITED2,CITED4,(CITED1)
  - SUMO1:TFAP2B
  - YEATS4
  - 'APOE gene '
  - 'CGB3 Gene '
  - KDM5B
  - 'ESR1 Gene '
  - 'HSPD1 gene '
  - homodimers:CITED2:PITX2 Gene
  - 'CREBBP '
  - CGA Gene
  - CDKN1A gene
  - homodimers:CGB gene
  - homodimer:VEGFA
  - EGFR gene
  - 'NPM1 '
  - TFAP2A,(TFAP2B,TFAP2C) homo- and heterodimers:YY1:ERBB2 gene
  - DEK
  - EP300
  - NOP2 gene
  - 'YEATS4 '
  - 'VEGFA gene '
  - homodimers:CITED2
  - 'CITED1 '
  - TFAP2A,(TFAP2B)
  - 'CDKN1A gene '
  - heterodimers:CITED2,CITED4,(CITED1):EP300:CREBBP
  - 'CGA '
  - 'TFAP2D '
  - 'KCTD1 '
  - 'TFAP2A-1 '
  - CDKN1A
  - SUMO1:TFAP2C
  - KCTD15
  - 'TFAP2C-G97-SUMO1 '
  - CGB3
  - 'EP300 '
  - 'ATAD2 '
  - PITX2 Gene
  - SUMO1:C93-UBE2I
  - KIT Gene
  - TFAP2A
  - homodimer
  - homodimer:YEATS4
  - and
  - homodimer:MYC:KDM5B:CDKN1A gene
  - 'YY1 '
  - APOE
  - KCTD1
  - 'UBE2I-G97-SUMO1 '
  - 'TFAP2A '
  - 'SUMO1-K21-TFAP2B '
  - 'TFAP2B '
  - 'WWOX '
  - TFAP2B homodimer
  - UBE2I
  - MYBL2 gene
  - heterodimers
  - homodimers:ESR1
  - gene
  - TFAP2C
  - CGB3 Gene
  - HSPD1 gene
  - TFAP2A,(TFAP2B,TFAP2C) homo- and heterodimers
  - TFAP2A-1 homodimer
  license: CC0
  name: Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
seo: CreativeWork
title: Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
wpid: WP4086
---